| Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433 S Monro, KL Colon, H Yin, J Roque III, P Konda, S Gujar, RP Thummel, ... Chemical reviews 119 (2), 797-828, 2018 | 1194 | 2018 |
| ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells D Vidovic, TT Huynh, P Konda, C Dean, BM Cruickshank, M Sultan, ... Cell Death & Differentiation 27 (1), 363-378, 2020 | 97 | 2020 |
| Near-infrared absorbing Ru (II) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma LM Lifshits*, JA Roque* III, P Konda*, S Monro, HD Cole, D von Dohlen, ... Chemical Science 11 (43), 11740-11762, 2020 | 85 | 2020 |
| Cytokines in oncolytic virotherapy JG Pol, ST Workenhe*, P Konda*, S Gujar*, G Kroemer Cytokine & Growth Factor Reviews 56, 4-27, 2020 | 60 | 2020 |
| MHC-I ligand discovery using targeted database searches of mass spectrometry data: implications for T-cell immunotherapies JP Murphy*, P Konda*, DJ Kowalewski, H Schuster, D Clements, Y Kim, ... Journal of Proteome Research 16 (4), 1806-1816, 2017 | 53 | 2017 |
| RTN4 knockdown dysregulates the AKT pathway, destabilizes the cytoskeleton, and enhances paclitaxel-induced cytotoxicity in cancers GP Pathak, R Shah, BE Kennedy, JP Murphy, D Clements, P Konda, ... Molecular Therapy 26 (8), 2019-2033, 2018 | 42 | 2018 |
| Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy P Konda, LM Lifshits, JA Roque III, HD Cole, CG Cameron, SA McFarland, ... Oncoimmunology 10 (1), 1863626, 2021 | 33 | 2021 |
| Therapy-induced MHC I ligands shape neo-antitumor CD8 T cell responses during oncolytic virus-based cancer immunotherapy JP Murphy, Y Kim, DR Clements, P Konda, H Schuster, DJ Kowalewski, ... Journal of proteome research 18 (6), 2666-2675, 2019 | 30 | 2019 |
| Multiplexed relative quantitation with isobaric tagging mass spectrometry reveals class I major histocompatibility complex ligand dynamics in response to doxorubicin JP Murphy, Q Yu, P Konda, JA Paulo, MP Jedrychowski, DJ Kowalewski, ... Analytical chemistry 91 (8), 5106-5115, 2019 | 30 | 2019 |
| Inhibition of pyruvate dehydrogenase kinase enhances the antitumor efficacy of oncolytic reovirus BE Kennedy, JP Murphy, DR Clements, P Konda, N Holay, Y Kim, ... Cancer research 79 (15), 3824-3836, 2019 | 27 | 2019 |
| Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of immunogenic cell … P Konda, JA Roque III, LM Lifshits, A Alcos, E Azzam, G Shi, CG Cameron, ... American journal of cancer research 12 (1), 210, 2022 | 25 | 2022 |
| Closely related reovirus lab strains induce opposite expression of RIG-I/IFN-dependent versus-independent host genes, via mechanisms of slow replication versus polymorphisms in … A Mohamed, P Konda, HE Eaton, S Gujar, JR Smiley, M Shmulevitz PLoS Pathogens 16 (9), e1008803, 2020 | 24 | 2020 |
| Quantitative temporal in vivo proteomics deciphers the transition of virus-driven myeloid cells into M2 macrophages DR Clements, JP Murphy, A Sterea, BE Kennedy, Y Kim, E Helson, ... Journal of proteome research 16 (9), 3391-3406, 2017 | 17 | 2017 |
| Genome-guided discovery of cancer therapeutic targets P Konda, S Garinet, EM Van Allen, SR Viswanathan Cell Reports 42 (8), 2023 | 11 | 2023 |
| Neuronal mitochondrial calcium uniporter deficiency exacerbates axonal injury and suppresses remyelination in mice subjected to experimental autoimmune encephalomyelitis SP Holman, AS Lobo, RJ Novorolsky, M Nichols, MDJ Fiander, P Konda, ... Experimental Neurology 333, 113430, 2020 | 9 | 2020 |
| How splicing confers treatment resistance in prostate cancer P Konda, SR Viswanathan Elife 11, e82070, 2022 | 6 | 2022 |
| NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma BE Kennedy, M Giacomantonio, JP Murphy, S Cutler, M Sadek, P Konda, ... Molecular Therapy-Oncolytics 24, 695-706, 2022 | 6 | 2022 |
| Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy S Gujar, JG Pol, V Kumar, M Lizarralde-Guerrero, P Konda, G Kroemer, ... Nature Protocols, 1-31, 2024 | 5 | 2024 |
| Immune checkpoint blockade augments changes within oncolytic virus-induced cancer MHC-I peptidome, creating novel antitumor CD8 T cell reactivities Y Kim, P Konda, JP Murphy, JA Paulo, SP Gygi, S Gujar Molecular & Cellular Proteomics 21 (2), 2022 | 5 | 2022 |
| A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma M Achom, A Sadagopan, C Bao, F McBride, Q Xu, P Konda, RW Tourdot, ... bioRxiv, 2023 | 4 | 2023 |
